Large-scale phosphoproteomic analysis of membrane proteins in renal proximal and distal tubule.

Epithelial Systems Biology Laboratory, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
AJP Cell Physiology (Impact Factor: 3.71). 03/2011; 300(4):C755-70. DOI: 10.1152/ajpcell.00360.2010
Source: PubMed

ABSTRACT Recent advances in mass spectrometry (MS) have provided means for large-scale phosphoproteomic profiling of specific tissues. Here, we report results from large-scale tandem MS [liquid chromatography (LC)-MS/MS]-based phosphoproteomic profiling of biochemically isolated membranes from the renal cortex, with focus on transporters and regulatory proteins. Data sets were filtered (by target-decoy analysis) to limit false-positive identifications to <2%. A total of 7,125 unique nonphosphorylated and 743 unique phosphorylated peptides were identified. Among the phosphopeptides identified were sites on transporter proteins, i.e., solute carrier (Slc, n = 63), ATP-binding cassette (Abc, n = 4), and aquaporin (Aqp, n = 3) family proteins. Database searches reveal that a majority of the phosphorylation sites identified in transporter proteins were previously unreported. Most of the Slc family proteins are apical or basolateral transporters expressed in proximal tubule cells, including proteins known to mediate transport of glucose, amino acids, organic ions, and inorganic ions. In addition, we identified potentially important phosphorylation sites for transport proteins from distal nephron segments, including the bumetanide-sensitive Na-K-2Cl cotransporter (Slc12a1 or NKCC2) at Ser(87), Thr(101), and Ser(126) and the thiazide-sensitive Na-Cl cotransporter (Slc12a3 or NCC) at Ser(71) and Ser(124). A subset of phosphorylation sites in regulatory proteins coincided with known functional motifs, suggesting specific regulatory roles. An online database from this study ( provides a resource for future studies of transporter regulation.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The renal distal tubule Na(+)-Cl(-)- cotransporter (NCC) reabsorbs less than 10% of the filtered Na(+) but is a key control point for blood pressure regulation by angiotensin II (AngII), angiotensin converting enzyme inhibitors (ACEI) and thiazide diuretics. This study aimed to determine whether NCC phosphorylation (NCCp) was regulated by acute (20-30 min) treatment with the ACEI captopril (12 μg/min x 20 min) or by a sub-pressor dose of AngII (20 ng/kg/min) in inactin anesthetized rats. By immuno-EM, NCCp was detected exclusively in or adjacent to apical plama membranes (APM) in controls and after ACEI or AngII treatment, while NCC total was detected in both APM and subapical cytoplasmic vesicles (SCV) in all conditions. In renal homogenates, neither ACEI nor AngII treatment altered NCCp abundance, assayed by immunoblot. However, by density gradient fractionation we identified a pool of low density APM in which NCCp decreased 50% in response to captopril and was restored during AngII infusion, and another pool of higher density APM that responded reciprocally, indicative of regulated redistribution between two APM pools. In both pools, NCCp was preferentially localized to Triton soluble membranes. Blue native gel electrophoresis established that APM NCCp localized to ~700 kDa complexes (containing γ-adducin) while unphosphorylated NCC in intracellular membranes primarily localized to ~400 kDa complexes; there was no evidence for native monomeric or dimeric NCC or NCCp. In summary, this study demonstrates that phosphorylated NCC, localized to multimeric complexes in the APM, redistributes in a regulated manner within the APM in response to ACEI and AngII.
    AJP Cell Physiology 10/2012; · 3.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diseases of the kidney filtration barrier are a leading cause of ESRD. Most disorders affect the podocytes, polarized cells with a limited capacity for self-renewal that require tightly controlled signaling to maintain their integrity, viability, and function. Here, we provide an atlas of in vivo phosphorylated, glomerulus-expressed proteins, including podocyte-specific gene products, identified in an unbiased tandem mass spectrometry-based approach. We discovered 2449 phosphorylated proteins corresponding to 4079 identified high-confidence phosphorylated residues and performed a systematic bioinformatics analysis of this dataset. We discovered 146 phosphorylation sites on proteins abundantly expressed in podocytes. The prohibitin homology domain of the slit diaphragm protein podocin contained one such site, threonine 234 (T234), located within a phosphorylation motif that is mutated in human genetic forms of proteinuria. The T234 site resides at the interface of podocin dimers. Free energy calculation through molecular dynamic simulations revealed a role for T234 in regulating podocin dimerization. We show that phosphorylation critically regulates formation of high molecular weight complexes and that this may represent a general principle for the assembly of proteins containing prohibitin homology domains.
    Journal of the American Society of Nephrology 02/2014; · 9.47 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There are three families of glucose transporters in the human genome, SLC2, SLC5 and SLC50. Here I review the structure and function of the SLC5 and SLC50 genes. The human sodium glucose cotransporter family (SLC5) has 12 human genes expressed in tissues ranging from epithelia to the central nervous system. The functions of all are known based on studies using heterologous expression systems: 10 are tightly coupled plasma membrane Na(+)/substrate cotransporters for solutes such as glucose, myoinositol, and anions; 1 is a Na(+)/Cl(-)/Choline cotransporter; and another is a glucose activated ion channel. The exon organization of most of the genes is similar in that they contain 14-15 exons. However, the choline transporter CHT is encoded in by the 8 exon SLC5A7 gene and the myoinositol SMIT transporter by the 1 exon SLC5A3 gene. Mutations in 3 SLC5 genes produce genetic phenotypes (glucose-galactose-malabsorption, renal glucosuria and hypothyroidism). Members of the SLC5 family are multifunctional membrane proteins in that they also behave as uniporters, urea and water channels, and urea and water cotransporters. The atomic structure of a closely related bacterial homolog has been solved and the structural core is common to six unrelated transporters, e.g. members of the SLC6 family of neurotransporters, and this leads to the conclusion that these work by a similar mechanism. The new SWEET class of glucose uniporters, SLC50, only has only one member in the human genome, SLC50A1. The SWEETs are found mostly in plants where they appear to be responsible for sugar efflux and are targeted by pathogens and symbionts for nutrition.
    Molecular Aspects of Medicine 04/2013; 34(2-3):183-196. · 10.30 Impact Factor